-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
For medical professionals only
1.
Serological examination
2.
Electrophysiological examination
Third, olfactory evaluation
4.
Neuroimaging examination
Fifth, intercardiac iodobenzylguanidine scintigraphy
6.
Clinical scoring scale
7.
Genetic testing
Parkinson disease[J].
Nat Rev Dis Primers,2017,3:17013.
DOI:10.
1038/nrdp.
2017.
13.
[2]Schrag A,Schott JM.
Epidemiological,clinical,and genetic characteristics of early-onset parkinsonism[J].
Lancet Neurol,2006,5(4):355-363.
DOI:10.
1016/S1474-4422(06)70411-2.
[3]Niemann N,Jankovic J.
Juvenile parkinsonism:differentialdiagnosis,genetics,and treatment[J].
Parkinsonism Relat Disord,2019,67:74-89.
DOI:10.
1016/j.
parkreldis.
2019.
06.
025.
[4]Mehanna R,Jankovic J.
Young-onset Parkinson's disease:itsunique features and their impact on quality of life[J].
Parkinsonism RelatDisord,2019,65:39-48.
DOI:10.
1016/j.
parkreldis.
2019.
06.
001.
[5] Chinese expert consensus on the diagnosis and treatment of early-onset Parkinson's disease ▼▼▼Click to read the original article to download the App
For more guidelines for the diagnosis and treatment of common neurological diseases, go to the "Clinical Decision Assistant App"!
Parkinson's disease (PD) is a common neurodegenerative disease that increases in prevalence with age [1].
Although PD is currently more common in the elderly, recent studies have found that some patients have an onset age earlier than 50 years old, called early-onset PD (early-onset Parkinson's disease, EOPD), accounting for 5%~10% of PD [2-4].
To determine whether it is early-onset Parkinson's disease, the "Chinese Expert Consensus on the Diagnosis and Treatment of Early-onset Parkinson's Disease" points out the following 7 auxiliary examination methods, let's take a look! Early detection, early intervention!
1.
Serological examination
Serum copper, serum ceruloplasmin, etc.
are helpful in differentiating
Wilson disease (HLD).
2.
Electrophysiological examination
EMG tremor testing is helpful in the analysis and evaluation
of tremor frequency, amplitude, and type.
Third, olfactory evaluation
Sniffin's Sticks test assesses olfactory function
.
4.
Neuroimaging examination
▍1.
Structural brain CT and MRI routine sequence examination
EOPD has no characteristic changes
.
It can distinguish HLD, spinal cerebellar ataxia (SCA), Huntington's disease (HD), and neurodegenerative disease of iron deposition in brain tissue (NBIA).
▍2, positron emission computed tomography (PET/PET-CT), single-photon emission computed tomography (SPECT)
Dopamine transporter (DAT) tracer imaging showing decreased uptake in the basal ganglia suggests EOPD
.
▍3.
Ultrasonic testing
EOPD shows abnormal enhancement of substantia nigra echo (>20mm2), large substantia nigra echo volume, and significantly enhanced substantia nigra
echo.
Fifth, intercardiac iodobenzylguanidine scintigraphy
May show cardiac desympathetic innervation, but EOPD may not be as suggestive as iPD
.
6.
Clinical scoring scale
Useful in understanding the clinical symptoms and severity
of EOPD patients.
The International Society of Movement Disorders Parkinson's Disease Composite Rating Scale (MDS-UPDRS) and Hoehn-Yahr Staging Scale assess motor symptoms, motor complications, and disease severity
.
The Non-Motor Symptom Rating Scale (NMSS), the Mini-Mental State Assessment Scale (MMSE), the Montreal Cognitive Scale (MoCA), and the Hamilton Depression Scale (HAMD) assess non-motor symptoms
.
A specific type of rating scale may be used to assess a particular aspect in detail
.
7.
Genetic testing
It can identify the cause and assist in diagnosis and differential diagnosis
.
Genetic counseling is required before testing, including family history, age of onset, clinical phenotype, etc
.
Detection technology methods and strategies: Sanger sequencing, next-generation sequencing
.
For Parkin, SNCA and other genes, multiple ligation probe amplification (MLPA) must be used to complete gene copy number detection
.
Denatured polyacrylamide electrophoresis and capillary electrophoresis were used to detect polynucleotide repeat amplification mutations, which could exclude SCA and HD
.
Parkin, GBA, LRRK2, PLA2G6, PINK1, SNCA, VPS13C, ATP13A2, VPS35, DJ-1 and other tests were carried
out.
What are the recommended medications for early-onset Parkinson's disease?
What are the precautions for using anti-Parkinson's drugs?
Open the Decision Assistant App Clinical Guidelines module
Search for disease names, dialogue with authoritative guides at home and abroad! 👇
Download the Decision Assistant App, the guide is free at any time~
References: [1] Poewe W, Seppi K, Tanner CM, et al.Parkinson disease[J].
Nat Rev Dis Primers,2017,3:17013.
DOI:10.
1038/nrdp.
2017.
13.
[2]Schrag A,Schott JM.
Epidemiological,clinical,and genetic characteristics of early-onset parkinsonism[J].
Lancet Neurol,2006,5(4):355-363.
DOI:10.
1016/S1474-4422(06)70411-2.
[3]Niemann N,Jankovic J.
Juvenile parkinsonism:differentialdiagnosis,genetics,and treatment[J].
Parkinsonism Relat Disord,2019,67:74-89.
DOI:10.
1016/j.
parkreldis.
2019.
06.
025.
[4]Mehanna R,Jankovic J.
Young-onset Parkinson's disease:itsunique features and their impact on quality of life[J].
Parkinsonism RelatDisord,2019,65:39-48.
DOI:10.
1016/j.
parkreldis.
2019.
06.
001.
[5] Chinese expert consensus on the diagnosis and treatment of early-onset Parkinson's disease ▼▼▼Click to read the original article to download the App